Your browser doesn't support javascript.
Bleeding Hazard of Percutaneous Tracheostomy in COVID-19 Patients Supported With Venovenous Extracorporeal Membrane Oxygenation: A Case Series.
Elmelliti, Hussam; Mutkule, Dnyaneshwar Pandurang; Imran, Muhammad; Shallik, Nabil Abdelhamid; Hssain, Ali Ait; Shehatta, Ahmed Labib.
  • Elmelliti H; Emergency Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar. Electronic address: HElmelliti@hamad.qa.
  • Mutkule DP; Medical Intensive Care Unit, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Imran M; Medical Intensive Care Unit, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Shallik NA; Department of Anesthesia, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medicine - Qatar, Doha, Qatar; Qatar University, Doha, Qatar; Tanta University, Tanta, Egypt.
  • Hssain AA; Medical Intensive Care Unit, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medicine - Qatar, Doha, Qatar.
  • Shehatta AL; Medical Intensive Care Unit, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medicine - Qatar, Doha, Qatar.
J Cardiothorac Vasc Anesth ; 2022 Sep 20.
Article in English | MEDLINE | ID: covidwho-2240506
ABSTRACT

OBJECTIVES:

Tracheostomy usually is performed to aid weaning from mechanical ventilation and facilitate rehabilitation and secretion clearance. Little is known about the safety of percutaneous tracheostomy in patients with severe COVID-19 supported on venovenous extracorporeal membrane oxygenation (VV-ECMO). This study aimed to investigate the bleeding risk of bedside percutaneous tracheostomy in patients with COVID-19 infection supported with VV-ECMO.

DESIGN:

A Retrospective review of electronic data for routine care of patients on ECMO.

SETTING:

Tertiary, university-affiliated national ECMO center.

PARTICIPANTS:

Patients with COVID-19 who underwent percutaneous tracheostomy while on VV-ECMO support.

INTERVENTIONS:

No intervention was conducted during this study. MEASUREMENTS AND MAIN

RESULTS:

Electronic medical records of 16 confirmed patients with COVID-19 who underwent percutaneous tracheostomy while on VV-ECMO support, including patient demographics, severity of illness, clinical variables, procedural complications, and outcomes, were compared with 16 non-COVID-19 patients. The SPSS statistical software was used for statistical analysis. The demographic data were compared using the chi-square test, and normality assumption was tested using the Shapiro-Wilk test. The indications for tracheostomy in all the patients were prolonged mechanical ventilation and sedation management. None of the patients suffered a life-threatening procedural complication within 48 hours. Moderate-to-severe bleeding was similar in both groups. There was no difference in 30- and 90-days mortality between both groups. As per routine screening results, none of the staff involved contracted COVID-19 infection.

CONCLUSIONS:

In this case series, percutaneous tracheostomy during VV-ECMO in patients with COVID-19 appeared to be safe and did not pose additional risks to patients or healthcare workers.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal subject: Anesthesiology / Cardiology Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal subject: Anesthesiology / Cardiology Year: 2022 Document Type: Article